Caribou Biosciences Inc Sustainability Reports
Caribou Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies. The company leverages its proprietary CRISPR technology platform to engineer therapies for the treatment of hematologic malignancies and other devastating diseases.
Sector: Professional & technical services
Country: United States
Exchange: Nasdaq
FIGI: BBG008G28LH7
1 reports from 2023 to 2023
